Safety and Immune Response to FMPV-1
Clinical trial NCT05238558 · COMPLETED
Trial details
- NCT number
- NCT05238558
- Sponsor
- Hubro Therapeutics AS
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-31
- Primary completion
- 2022-10-31
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.